Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis

Adjuvant chemotherapy after surgery improves survival of patients with stage II–III, resectable gastric cancer. However, the overall survival benefit observed after adjuvant chemotherapy is moderate, suggesting that not all patients with resectable gastric cancer treated with adjuvant chemotherapy b...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The lancet oncology 2018-05, Vol.19 (5), p.629-638
Hauptverfasser:	Cheong, Jae-Ho, Yang, Han-Kwang, Kim, Hyunki, Kim, Woo Ho, Kim, Young-Woo, Kook, Myeong-Cherl, Park, Young-Kyu, Kim, Hyung-Ho, Lee, Hye Seung, Lee, Kyung Hee, Gu, Mi Jin, Kim, Ha Yan, Lee, Jinae, Choi, Seung Ho, Hong, Soonwon, Kim, Jong Won, Choi, Yoon Young, Hyung, Woo Jin, Jang, Eunji, Kim, Hyeseon, Huh, Yong-Min, Noh, Sung Hoon
Format:	Artikel
Sprache:	eng
Schlagworte:	5-Fluorouracil Bioinformatics Biomarkers Chemotherapy Colorectal cancer Decision making Gastrectomy Gastric cancer Gene expression Medical prognosis Oxaliplatin Paraffin Patients Polymerase chain reaction R&D Research & development Studies Surgery Survival Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!